HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 922336Generated: November 1, 2026
Hydrochloric Acid → Pexmetinib hydrochloride
https://huagongshe.com/reaction/922336
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | Pexmetinib | HCID 24765037 | — |
| Product | Pexmetinib hydrochloride | HCID 71712232 | — |
Reaction Steps
Amorphous 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea (200 mg, 0.359 mmol, 1.0 equivalent) was added to a round bottom flask that had been flame dried under a nitrogen atmosphere. THF (3.0 mL) was added and the mixture was stirred at ambient temperature until the solids were dissolved. HCl in 1,4-dioxane (4M, 135 μL, 0.54 mmol, 1.5 equivalents) was added dropwise with rapid stirring, and the mixture was stirred overnight at ambient temperature. The solids were isolated by vacuum filtration. The solids were washed with methyl tert-butyl ether (MTBE) and then with ether. The solids were dried under vacuum at 40° C. overnight to yield 150 mg 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride Form A (0.252 mmol, 70% theoretical yield). Methods used to characterize this material are described in Examples 1-C and 1-D.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09278936B2 |
|---|
| Source dataset | uspto-grants-2016_03 |
|---|
| ORD ID | ord-a538b3cd3c4147eea0305df111c20f8d |
|---|
| Source note | uspto-grants-2016_03 |
|---|